4th Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$338,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
JOSEPH M GANLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Proposals to repeal LIFO

LobbyistCovered position, as disclosed
JOSEPH M GANLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Incentives for health information technology, Affordable Care Act implementation, and other healthcare policy issues. Proposed regulation of medical software. H.R. 3303 "SOFTWARE Act of 2013". S. 2007 "PROTECT Act of 2014". S.2977 "MEDTECH Act"

LobbyistCovered position, as disclosed
JOSEPH M GANLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2977 (113th), H.R. 3303 (113th), S. 2007 (113th)

Medicare/Medicaid MMM

Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93) S.806/H.R.800 "To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare"

LobbyistCovered position, as disclosed
MATT BROW —
JOSEPH M GANLEY —
KEAGAN R LENIHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 806 (113th), H.R. 800 (113th), H.R. 2869 (113th), H.R. 4302 (113th)

Pharmacy PHA

Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"

LobbyistCovered position, as disclosed
JOSEPH M GANLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2862 (113th), H.R. 4709 (113th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.